Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mesenchymal change and drug resistance in neuroblastoma.

The Journal of surgical research - 1 Jan 2015

Naiditch Jessica A, Jie Chunfa, Lautz Timothy B, Yu Songtao, Clark Sandra, Voronov Dimitry, Chu Fei, Madonna Mary Beth

Abstract excerpt

BACKGROUND: Metastatic initiation has many phenotypic similarities to epithelial-to-mesenchymal transition, including loss of cell-cell adhesion, increased invasiveness, and increased cell mobility. We have previously demonstrated that drug resistance is associated with a metastatic phenotype in neuroblastoma (NB). The purpose of this project was to determine if the development of doxorubicin resistance is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Cell Adhesion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Doxorubicin

Share to Drug Resistance, Neoplasm

Share to Epithelial-Mesenchymal Transition

Share to Neoplasm Invasiveness

Share to Neuroblastoma

Source

Identifiers

PMID: 25128389
DOI: 10.1016/j.jss.2014.07.018

Genes

ILK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mesenchymal change and drug resistance in neuroblastoma.PMID 25128389Read ↗

The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitroSemantic proximity Read ↗

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistanceSemantic proximity Read ↗

A Context-Dependent Role for MiR-124-3p on Cell Phenotype, Viability and Chemosensitivity in Neuroblastoma in vitroSemantic proximity Read ↗

Establishment and characterization of 18 Sarcoma Cell Lines: Unraveling the Molecular Mechanisms of Doxorubicin Resistance in Sarcoma Cell Lines.Semantic proximity Read ↗

Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic StrategiesSemantic proximity Read ↗

Epithelial-to-mesenchymal transition and drug resistance: transitioning away from deathSemantic proximity Read ↗

RacGAP1 Is a Novel Downstream Effector of E2F7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell CarcinomaSemantic proximity Read ↗

Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine SignalingSemantic proximity Read ↗

Stem cell pathways and Notch signaling an emerging role in the development of acquired Drug Resistance in NeuroblastomaSemantic proximity Read ↗

Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in CholangiocarcinomaSemantic proximity Read ↗

Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes.Semantic proximity Read ↗

Epithelial–mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCCSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.